Key facts
- 23andMe CEO Anne Wojcicki discussed the company's history, including its rise, bankruptcy, and rebirth.
- Wojcicki aims to transform 23andMe into a scientific platform for global health discoveries.
- The buyback is being funded with Wojcicki's personal capital.
23andMe CEO Anne Wojcicki sat down with Emily Chang on The Circuit to discuss the personal genetics company's trajectory. The conversation covered the company's rise, its period of bankruptcy, and its subsequent rebirth. Wojcicki articulated her vision for transforming 23andMe into a scientific platform focused on advancing global health discoveries. She also noted that the buyback of the company is being funded through her personal capital, underscoring her commitment to this new direction.